No abstract available
MeSH terms
-
Alefacept
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Clinical Trials as Topic*
-
Dermatologic Agents / adverse effects
-
Dermatologic Agents / therapeutic use
-
Humans
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / immunology
-
Piperidines
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / genetics
-
Pyrimidines / therapeutic use
-
Pyrroles / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
-
Ustekinumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
Interleukin-17
-
Piperidines
-
Pyrimidines
-
Pyrroles
-
Recombinant Fusion Proteins
-
Thalidomide
-
tofacitinib
-
Alefacept
-
Ustekinumab
-
apremilast